Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing
Our cutting-edge Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing is a comprehensive diagnostic tool designed to provide critical insights into a patient’s antibody profile. This information equips healthcare professionals with the knowledge needed to make informed decisions about transfusion and transplantation compatibility.
How it Works:
- 🔘 Screening Phase: A small blood sample is meticulously tested against a panel of known red blood cell (RBC) antigens. State-of-the-art techniques enable us to accurately detect and identify any antibodies that may be present in the patient’s bloodstream.
- 🔘 Reflex Stage: If an antibody is detected, the test proceeds to the reflex stage. Here, in-depth investigations are conducted to determine the specific antibody’s identity, titer, and antigen typing. This additional analysis provides crucial information about the nature and strength of the antibody, enabling healthcare professionals to tailor treatment plans accordingly.
- 🔘 Detection of Unexpected Antibodies: Identifies antibodies that may pose risks during transfusions or organ transplants.
- 🔘 Titer Assessment: Helps gauge the level of antibodies in the blood, essential for monitoring disease progression and treatment effectiveness.
Our Commitment: By leveraging cutting-edge technology and skilled laboratory professionals, we ensure the accuracy and reliability of our test results. Healthcare providers can rely on the findings of the Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing to guide patient care decisions.
In summary, our Antibody Screen test empowers healthcare professionals with the information needed to make informed decisions regarding transfusion and transplantation compatibility. Trust our expertise and technology to provide accurate results that enhance patient care and safety.